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the contrary that early operation was cost-effective, but
their sensitivity analysis found that the cost-effectiveness
was inversely related to the operative mortality rate and dis-
appeared as it approached 10%. Despite its significance, the
current operative mortality rate for open repair of intact
AAAs across the United States remains poorly defined.
Lawrence et al3 reported that the operative mortality rate
in the United States for nonruptured AAAs was 8.4% dur-
ing 1994. This value is significantly greater than that
reported from the Canadian national experience (4.8%),4
Medicare patients (5.5%),5 Veterans Affairs Medical
Centers (4.9%),6 the state of Maryland (3.5%),7 and a
review of several institutional series (4%).8 However, it is
consistent with reports from the national experience in the
Netherlands (6.8%)9 and the states of Michigan (7.5%)10
and California (6.5%).11
Approval of the Aneurex (Medtronic, Santa Rosa,
Calif) and Ancure (Guidant, Menlo Park, Calif) endovas-
cular devices for AAA repair has further challenged the
results of traditional open repair of intact AAAs. The
endovascular approach offers several theoretical advan-
tages; however, the mortality rates for the initial nonran-
domized trials of endovascular versus open repair have not
been significantly different.12-14 Appropriate comparison
of the endovascular and standard techniques requires ran-
Data regarding the outcome after open operative repair
of intact abdominal aortic aneurysms (AAAs) are critical in
the decision algorithms for recommending both operation
and the specific type of treatment (open vs endovascular).
Elective repair has traditionally been recommended for
good risk patients with aneurysms of 5 cm or more in
diameter. However, the UK Small Aneurysm Trial, a
prospective, randomized, controlled trial, reported no sur-
vival benefit at 6 years for the repair of aneurysms of 4.0 to
5.5 cm, partly because of the operative mortality rate of
5.8%.1 Schermerhorn et al2 incorporated the results of the
UK Trial into a decision analysis model and concluded to
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Objectives: The purpose of this study was to determine the current outcome in the United States and to identify pre-
dictors of mortality and “bad outcome” after open, intact abdominal aortic aneurysm (AAA) repair.
Methods: In a retrospective analysis, data were obtained from the Nationwide Inpatient Sample during 1994-1996. The
Nationwide Inpatient Sample is a 20% all-payer stratified sample of nonfederal United States hospitals. Patients older
than 49 years were identified by the presence of primary diagnostic (441.4-intact AAA) and procedure (38.44-resec-
tion of abdominal aorta with replacement) codes of the International Classification of Diseases, Ninth Revision (ICD-
9). In-hospital mortality rate, discharge disposition, bad outcome (death or discharge to an institution), complications
(ICD-9 postoperative codes), length of stay, and charges were determined. The mortality rate and bad outcome were
analyzed by the use of patient demographics (age, sex, race), patient comorbidities (ICD-9 diagnostic codes), calendar
year, and hospital characteristics (size, location, teaching status) with univariate and multivariate analyses.
Results: We identified 16,450 intact AAAs repairs during the study years. The mean patient age was 72 ± 7 (± SD)
years, and most patients were male (79.7%) and white (94.6%). Most repairs were performed at large (67.3%), urban
(92.5%), and nonteaching (66.7%) institutions. The in-hospital mortality rate was 4.2%, the overall complication rate
was 32.4%, and 91.2% of patients were discharged home, whereas the bad outcome rate was 12.6%. The median length
of stay was 8 days (mean, 10.0 ± 8.1), and median hospital charges were $28,052 (mean, $35,681 ± $33,006) in 1996
dollars. Multivariate analysis showed that the mortality rate (P < .05) increased with age (70-79 years, 1.8 odds ratio
[OR] [95% CI, 1.4-2.3], > 79 years, 3.8 OR [95% CI, 2.9-4.9]), sex (female, 1.6 OR [95% CI, 1.3-1.9]), cerebral
vascular occlusive disease (1.8 OR [95% CI, 1.3-2.5]), preoperative renal insufficiency (9.5 OR [95% CI, 7.7-11.7]),
and more than three comorbidities (11.2 OR [95% CI, 3.6-35.4]). Multivariate analysis also showed that bad out-
come was associated with the same variables in addition to hospital size (small/medium), year of procedure (1996),
chronic obstructive pulmonary disease, and two to three comorbidities.
Conclusions: Outcome after open repair of intact AAA across the United States is quite good. Older, sicker patients may
benefit from nonoperative treatment or the potentially lower risk endovascular approaches. (J Vasc Surg 2001;33:304-11.)
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domized, controlled trials, but this may not be feasible
because of patient preferences and the inability to enroll
patients. Comparison of the two techniques with nonran-
domized controls is less optimal, but mandates defining
the current outcome for open AAA repair. This study was
designed to determine the outcome and to identify pre-
dictors of death and “bad outcome” after open, intact
AAA repair in the United States during 1994-1996.
METHODS
Data were obtained for calendar years 1994-1996
from the National Inpatient Sample, which is the largest
all-payer inpatient care database and contains data from
over 6 million annual discharges from more than 900 hos-
pitals in 19 states.15-18 The database approximates a 20%
stratified sample of community hospitals with the stratifi-
cation criteria including geographic region, ownership,
location, teaching status, and bed size.18 The discharge
abstract includes the diagnostic and procedure codes of
the International Classification of Disease, Ninth Revision
(ICD-9),19 admission/discharge status, demographics,
payment source, charges, length of stay (LOS), and hospi-
tal characteristics.
A dataset of patients undergoing repair of intact (non-
ruptured) AAAs was constructed with combinations of the
ICD-9 diagnostic and procedure codes. A total of 22,224
patients were identified from the database with the diag-
nostic code 441.4 (abdominal aneurysm without mention
of rupture) in any position and the presence of any poten-
tial procedure code for AAA repair (38.44, 38.34, 38.36,
38.40, 38.46, 38.60, 38.64, 38.66, 38.84, 39.24, 39.25,
39.26, 39.52, 39.56, 39.57).10 A total of 20,720 patients
were identified with the primary diagnostic code 441.4
and any of the potential procedure codes, whereas 16,610
patients were identified with the primary diagnostic code
441.4 and the primary procedure code 38.44 (resection of
vessel with replacement, abdominal aorta). Previous analy-
ses with the primary diagnostic code 441.4 and all poten-
tial procedure codes for AAA repair found no difference in
the mortality rate or other trends when compared with the
procedure code 38.44 alone.10 The analysis was restricted
to discharges with the primary diagnostic and procedure
codes 441.4 and 38.44, respectively, in an attempt to
include only patients who underwent aortic reconstruc-
tion for aneurysmal disease. Patients younger than 50
years and those with a secondary diagnostic code for rup-
tured AAAs (441.3, 441.5), aortic dissection (441.0),
thoracic/thoracoabdominal aortic aneurysm (441.1,
441.2, 441.6, 441.7), coarctation of the aorta (747.1),
Marfan syndrome and other congenital anomalies
(759.8), gonadal dysgenesis–Turner’s syndrome (758.6),
and polyarteritis nodosa (446.0) were subsequently
excluded from the analysis.10
The dataset was analyzed by the use of patient demo-
graphics and hospital characteristics. The race classification
was simplified to include only white, black, and other,
although the race criterion was not available from the dis-
charge data from every state. The hospital characteristics
of location, teaching status, and size were obtained from
the stratification criteria.18 Hospital bed size categories
were based on the location and teaching status. Outcome
measures analyzed included mortality, postoperative com-
plications, LOS, discharge disposition, and hospital
charges. Mortality was defined as in-hospital death, and
the complications were identified by the presence of ICD-
9 complication codes including the complications of med-
ical care (996-999) and cardiac complication (997.1).20
The disposition among those discharged alive was simpli-
fied in the analysis to either home (routine, home health,
against medical advice) or another institution. Patients
who either died in-hospital or were discharged to another
institution were arbitrarily considered as having a bad out-
come. The charges analyzed reflect only those for the
inpatient hospitalization during which the procedure was
performed, and all charges were converted to 1996 dollars
by the use of a 4% annual rate of inflation.
Mortality and bad outcome were further analyzed
with multivariate analysis. The predictors identified with
the univariate analysis were incorporated into the multi-
variate model. The univariate analysis included demo-
graphics, comorbidities, calendar year, and hospital
characteristics. The comorbidities were identified by the
ICD-9 diagnostic codes for diabetes mellitus (250.0-
250.9), hypertension (401.0-405.9), preoperative renal
insufficiency (584.0-586.0, 403.0-403.9), chronic
obstructive pulmonary disease (490.0-496.0), ischemic
heart disease (410.0-414.9), cerebral vascular occlusive
disease (430.0-438.0), and peripheral arterial occlusive
disease (440.0-440.9, 443.0-443.9).10 The number of
secondary diagnostic codes were classified into the groups
0-1, 2-3, and more than 3 after excluding the complica-
tions of surgical and medical care (996-999).10
The criteria used to construct the dataset were vali-
dated at the Shands Hospital at the University of Florida
College of Medicine. Data were obtained from the dis-
charge abstracts during calendar years 1995-1999. A total
of 225 discharge abstracts were identified with the diag-
nostic code 441.4 in any position and any of the 15 possi-
ble procedure codes. A total of 198 discharges were
identified with the principal diagnostic code 441.4 and
any of the possible procedure codes, whereas 153 dis-
charges were identified with the combination of the prin-
cipal diagnostic code 441.4 and the principal procedure
code 38.44. The medical record was reviewed to confirm
that these 153 discharges corresponded to intact AAA
repairs. Nine patients (thoracoabdominal aortic aneurysm,
2; endovascular repair, 4; ruptured aneurysm, 1; visceral
artery aneurysm, 1; aortic anastomotic pseudoaneurysm,
1) were erroneously included in the dataset for an overall
patient selection accuracy of 94%. All four endovascular
repairs were performed after 1996.
Data are presented as the mean ± SD unless otherwise
specified. The outcomes after AAA repair were compared
with χ2 analysis for the categorical variables and analysis of
variance for the continuous variables. A P value less than
.05 was accepted as significant. A multivariate logistic
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model was constructed for the multivariate analysis, and
those variables found to be either significant or approach-
ing significance (P < .10) with univariate analysis were
incorporated into the multivariate analysis. The multivari-
ate odds ratios (ORs) are reported with the 95% CIs. All
the data analyses were performed with SAS version 8.0
(SAS Institute Inc, Cary, NC).
RESULTS
A total of 16,450 discharges during which patients
underwent repair of intact AAAs were identified in the
dataset. The mean patient age was 71.6 ± 7.4 years (Table
I), and those aged between 70 and 79 years comprised the
largest group. Most patients were male and white among
those whose race was classified in the discharge abstract
(83.6%). Most repairs were performed in large, nonteach-
ing, and urban institutions. The in-hospital mortality rate
was 4.2%, and 32.4% of the patients experienced some type
of complication, although the overwhelming majority was
discharged home (Table II). This corresponded to an over-
all bad outcome rate of 12.6%. The median LOS was 8
days, whereras the median hospital charges were $28,052.
Outcome after intact AAA repair varied significantly by
patient demographics (Table III) and hospital characteris-
tics (Table IV). The mortality rate and percentage of
patients discharged to another institution were both
greater for women, and the corresponding bad outcome
rate was almost double, although the mean patient age was
almost 2 years older. The mean LOS and hospital charges
were also greater for women. Similarly, the mortality rate,
overall complication rate, LOS, and charges were all
greater among black patients, although the mean patient
age was almost 2 years younger. Predictably, all outcome
measures, including mortality rate, were worse for the
older groups of patients. Notably, almost 30% of patients
older than 79 years had a bad outcome in contrast to
approximately 5% among those aged between 50 and 59
years. Interestingly, both the cardiac and overall complica-
tion rates, the LOS, and the hospital charges were all
greater at the teaching institutions, whereas the overall
complication rate was lower at urban institutions, although
the hospital charges were greater. Finally, fewer patients
were discharged to another institution from large hospitals,
and the corresponding bad outcome rate was less.
Further analysis of the predictors of mortality demon-
strated that the presence of multiple comorbidities and the
individual diagnostic codes for cerebral vascular occlusive
disease, chronic obstructive pulmonary disease, and pre-
operative renal insufficiency were all associated with
increased mortality with univariate analysis (Appendix).
Surprisingly, the presence of diagnostic codes for hyper-
tension and ischemic heart disease was associated with a
decreased mortality rate. Multivariate analysis found that
mortality was significantly greater for women, older
patients, and patients with cerebral vascular occlusive dis-
ease, preoperative renal insufficiency, and multiple
comoribidities and was lower for patients with hyperten-
sion and ischemic heart disease (Table V). Notably, the
OR for patients older than 79 years was greater than
threefold higher than the reference group, whereas the
ORs for those with preoperative renal insufficiency and
more than three comorbidities were both greater than
ninefold higher. Similarly, the calendar year, multiple
comorbidities, and diagnostic codes for cerebral vascular
occlusive disease, chronic obstructive pulmonary disease,
and preoperative renal insufficiency were additionally asso-
ciated with an increased incidence of bad outcome with
univariate analysis, whereas hypertension and ischemic
heart disease were associated with a lower incidence
(Appendix). Furthermore, all the univariate predictors of
bad outcome were significant with multivariate analysis,
and the corresponding ORs were dramatically increased
for older patients and those with preoperative renal insuf-
ficiency and multiple comorbidities (Table VI).
DISCUSSION
The results suggest that the level of care across the
United States as defined by a 4.2% mortality rate, a 91.2%
discharge home rate, an 8-day median LOS, and a
$28,052 median hospital charge rate is good. Several of
Table I. Summary of patient demographics and hospital
characteristics for intact AAA repair
Patient demographics
Age 71.6 ± 7.4 y
50-59 y 960 (5.8%)
60-69 y 5,228 (31.8%)
70-79 y 7,965 (48.4%)
> 79 y 2,295 (14.0%)
Male 13,114 (79.7%)
Female 3,340 (20.3%)
White 13,009 (94.7%)
Black 286 (2.1%)
Other race 450 (3.3%)
Hospital characteristics
Small 1,117 (6.8%)
Medium 4,247 (25.9%)
Large 11,039 (67.3%)
Teaching 5,513 (33.3%)
Nonteaching 10,937 (66.7%)
Urban 15,178 (92.5%)
Rural 1,272 (7.5%)
Table II. Summary of patient outcome after intact AAA
repair
In-hospital death 4.2%
Discharge institution 8.8%
Discharge home 91.2%
Bad outcome 12.6%
Any complication 32.4%
Cardiac complication 7.9%
Mean LOS 10.0 ± 8.1 d
Median LOS 8 d
Mean hospital charges $35,681 ± $33,006
Median hospital charges $28,052
LOS, Length of stay.
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the outcome measures varied significantly by patient
demographics and hospital characteristics in the univariate
analysis. Notably, the mortality rate was greater for both
women and black patients, and the corresponding bad
outcome rate was almost double for women. Multivariate
analysis of both mortality and bad outcome confirmed
most of the univariate predictors and demonstrated that
ORs for both untoward events increased dramatically for
patients older than 79 years, those with preoperative renal
insufficiency, and those with multiple comorbidities.
These overall good results are particularly noteworthy
because they reflect one of the largest, all-payer, contem-
porary experiences of open intact AAA repairs in the
United States. Furthermore, the series includes sympto-
matic aneurysms, emergency repairs for nonruptured
aneurysms, juxtarenal and suprarenal aneurysms, inflam-
matory aneurysms, and those repairs performed concomi-
tant with other procedures.
The reported outcome compares favorably with the
better national,4-6 state,7 and institutional8 series for open,
intact AAA repairs. The mortality rate is almost identical
to that reported by Ernst8 (4%) in a collective review of
several series primarily from academic medical centers
encompassing 6500 patients. Furthermore, it is only
slightly higher than that reported by Dardik et al7 (3.5%,
N = 2335) from the state of Maryland during 1990-1995.
The mortality rate is significantly lower than that reported
by Katz et al10 (7.5%, N = 8185) from the state of
Michigan during 1980-1990. This difference may be
partly explained by the time frame of the current study
and the ongoing improvements in clinical care. The mor-
tality rate for intact AAAs in the study by Katz et al10
decreased from 13.6% in 1980 to 5.6% in 1990; similar
trends have been reported in the state of California.11 The
mortality rate in the current study is dramatically different
from the study by Lawrence et al3 (8.4%), which
attempted to define the epidemiology of aneurysm repairs
across the United States in 1994. The explanations for this
marked difference potentially include differences in the
year of study, the database, and the method used to con-
struct the dataset. Their study used the National Hospital
Discharge Survey, although it has been reported to com-
Table III. Impact of patient demographics on outcome
Mortality Discharge Bad Any Cardiac
Group Age (y) rate institution outcome complication complication LOS (d) Charges ($)
Sex
Male 71.2 ± 7.4 3.7% 7.4% 10.8% 32.1% 7.7% 9.9 ± 8.2 35,199 ± 33,035 
Female 73.1 ± 7.2 6.1% 14.4% 19.6% 33.3% 8.6% 10.7 ± 8.0 37,565 ± 32,830
P value < .0001 < .0001 < .0001 < .0001 .18 .07 < .0001 < .05
Race
White 71.7 ± 7.3 4.2% 8.8% 12.7% 32.7% 8.4% 10.0 ± 8.1 35,645 ± 33,040
Black 69.6 ± 7.5 7.0% 8.7% 15.0% 39.5% 7.7% 12.3 ± 8.3 41,909 ± 36,921
Other 71.3 ± 7.4 2.2% 8.2% 10.2% 34.7% 6.2% 9.8 ± 8.5 40,491 ± 40,533
P value < .0001 < .05 .9 .14 < .05 .24 < .0001 < .0001
Age
50-59 56.0 ± 2.6 2.2% 2.6% 4.7% 25.4% 3.2% 8.3 ± 5.7 30,330 ± 23,691
60-69 65.6 ± 2.7 2.1% 4.2% 6.2% 29.9% 5.5% 9.1 ± 7.4 32,569 ± 27,910
70-79 74.2 ± 2.8 4.3% 8.8% 12.7% 32.9% 8.7% 10.3 ± 8.3 36,802 ± 35,231
> 79 82.9 ± 2.8 9.2% 22.7% 29.8% 39.2% 12.4% 11.8 ± 9.4 41,082 ± 37,687
P value NA < .0001 < .0001 < .0001 < .0001 < .0001 < .0001 < .0001
LOS, Length of stay; NA, not applicable.
Table IV. Impact of hospital characteristics on outcome
Mortality Discharge Bad Any Cardiac
Group rate institution outcome complication complication LOS (d) Charges ($)
Nonteaching 4.2% 8.9% 12.7% 31.3% 7.4% 9.7 ± 7.0 35,165 ± 28,796
Teaching 4.1% 8.6% 12.4% 34.6% 8.8% 10.7 ± 10.0 36,750 ± 40,240
P value .54 .57 .51 < .0001 < .05 < .0001 < .05
Rural 4.0% 9.0% 12.7% 36.9% 9.1% 9.9 ± 7.5 27,965 ± 19,813
Urban 4.2% 8.8% 12.6% 32.0% 7.8% 10.0 ± 8.2 36,310 ± 33,789
P value .69 .76 .94 < .001 .09 .5 < .0001
Small 4.9% 12.5% 16.8% 33.7% 8.7% 10.3 ± 7.7 36,706 ± 29,865
Medium 4.4% 10.6% 14.6% 33.6% 7.9% 10.1 ± 8.6 36,580 ± 33,653
Large 4.0% 7.7% 11.4% 31.8% 7.8% 10.0 ± 8.0 35,256 ± 33,057
P value .11 < .0001 < .0001 .074 .57 .27 .06
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pare favorably with the Nationwide Inpatient Sample.18
The number of aneurysm repairs in their study was deter-
mined by reviewing a limited number of records and esti-
mating the total based on a population weight assigned by
the incidence of the disease process in the overall popula-
tion. Furthermore, the ICD-9 codes used to identify the
repairs and any exclusion criteria used to ensure that only
intact aneurysms were included were not detailed in their
report. Regardless, the median LOS in our study was iden-
tical to that reported by Lawrence et al3 (8 days) and also
compared favorably with that reported by Dardik et al7
(10.6 ± 0.2 days). Interestingly, the LOSs in the current
study approach those reported from clinical pathways for
elective aortic reconstructions.21,22
The current study may help define the most appropri-
ate treatment for patients with intact AAAs. The overall
mortality rate appears to justify the recommendation for
repair of 5-cm AAAs in good risk patients. The 4.2% mor-
tality rate may even justify lowering the size threshold to 4
cm as suggested by the national vascular surgery soci-
eties23 and a recent decision analysis.24 However, it should
be emphasized that our study was a retrospective analysis
designed to look at the outcome in the United States and
not to define the size threshold for repair. The well-
designed UK Small Aneurysm Trial did not support repair
of AAAs between 4.0 and 5.5 cm.1 Hopefully, this issue
will be further defined by the results of the Department of
Veterans Affairs Aneurysm Detection and Management
Study.25 The excessive mortality rates predicted by the
multivariate model for several subsets of patients suggest
that nonoperative management or endovascular repair
may be a better approach than open repair in such
patients. Admittedly, the early endovascular trials have not
shown a significant survival benefit, although it is gener-
ally assumed that this approach is associated with a lower
mortality rate and may be well suited for high-risk
patients. Notably, Finlayson et al26 used a decision analy-
sis model to define the threshold for endovascular repair
and reported that the new technique may lower the repair
threshold for older, sicker patients. It should be empha-
sized that the excessive mortality and bad outcome rates
associated with preoperative renal insufficiency may be
partly due to inappropriate coding for postoperative renal
failure in patients without preoperative renal compromise.
However, the observation that preoperative renal insuffi-
ciency is associated with an increased perioperative mor-
tality rate has been reported in several other series.4,7,10,27
The difference in outcome by sex is consistent with
other population studies. Several statewide experi-
ences7,10,11 have reported that the mortality rate is signifi-
cantly higher for women, and Dardik et al7 reported that
both LOS and hospital charges were greater. Katz et al28
analyzed the sex differences in patients with AAAs in
Michigan and concluded that women were less likely to
undergo operative repair and less likely to be discharged
alive after repair. Increased mortality rates have also been
reported for women undergoing both coronary artery
Table V. Multivariate analysis of mortality
Variable OR (95% CI) P value
Sex 
Male* — —
Female 1.6 (1.3-1.9) < .0001
Race 
White* — —
Black 1.6 (1.0-2.7) .07
Other 0.6 (0.3-1.2) .12
Age (y)
50-59 1.1 (0.7-2.0) .67
60-69* — —
70-79 1.8 (1.4-2.3) < .0001
> 79 3.8 (2.9-4.9) < .0001
Individual comorbidities
No condition* — —
Hypertension 0.5 (0.4-0.6) < .0001
Cerebral vascular 1.8 (1.3-2.4) < .001
occlusive disease
Ischemic heart disease 0.8 (0.7-1.0) < .05
Chronic obstructive 1.0 (0.9-1.3) .67
pulmonary disease
Renal insufficiency 9.5 (7.7-11.7) < .0001
Number of comorbidities 
0-1* — —
2-3 3.2 (1.0-10.5) .06
> 3 11.2 (3.6-35.4) < .0001
*Reference group for comparison.
Table VI. Multivariate analysis of bad outcome
Variable OR (95% CI) P value
Sex 
Male* — —
Female 1.8 (1.6-2.0) < .0001
Age (y)
50-59 0.9 (0.6-1.2) .39
60-69* — —
70-79 2.0 (1.7-2.3) < .0001
> 79 5.9 (5.1-6.9) < .0001
Institution size
Small 1.7 (1.4-2.1) < .0001
Medium 1.4 (1.2-1.5) < .0001
Large* — —
Calendar year
1994* — —
1995 1.1 (1.0-1.2) .25
1996 1.2 (1.1-1.4) < .05
Individual comorbidities
No condition* — —
Hypertension 0.6 (0.55-0.68) < .0001
Cerebral vascular 2.2 (1.9-2.7) < .0001
occlusive disease
Ischemic heart disease 0.7 (0.6-0.8) < .0001
Chronic obstructive 1.3 (1.1-1.4) < .0001
pulmonary disease
Renal insufficiency 6.9 (5.9-8.1) < .0001
Number of comorbidities 
0-1* — —
2-3 1.6 (1.1-2.3) < .05
> 3 4.2 (3.0-5.9) < .0001
*Reference group for comparison.
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bypass grafting29 and heart transplantation30 with ORs
comparable to the current study. The explanation for this
sex difference in outcome is not obvious from our data. The
mean age of the women who underwent operative repair in
our study and in several similar population studies3,7,10 was
significantly greater. Furthermore, Dardik et al7 reported
that the women in their study were sicker as reflected by
their medical severity score. However, the sex difference
persisted in our multivariate model despite the inclusion of
terms for both patient age and comorbidities. The sex dif-
ference in outcome may also have been due to an increased
incidence of suprarenal aneurysms among women.31,32
Our data also suggest that there was a significant racial
difference in outcome. Dardik et al7 reported similarly
that the LOS, hospital charges, and mortality as deter-
mined with univariate analysis were all significantly greater
for black patients although the difference in mortality also
dropped out of their multivariate model. No difference in
mortality by race has been reported from several of the
other population studies of intact AAAs, although race has
not been universally included3,4 or the number of black
patients undergoing repair has been small.10 Marked racial
disparities in the incidence of several complex cardiovascu-
lar procedures have been reported including coronary
artery bypass grafting,33 carotid endarterectomy,34 and
lower extremity revascularization.35 The explanations for
this marked racial disparity in outcome potentially includes
differential access to care, differences in the underlying
disease process, delay in presentation, and racial bias
among health care providers. The relatively small number
of aneurysm repairs reported in black patients suggests
that the incidence may indeed be different. The observed
racial disparity in our study must be interpreted with some
caution because race data were unavailable in the dis-
charge abstracts from every state. These incomplete data
compromise the stratification criteria of the hospitals and
the validity of the 20% United States sample in regard to
the race classification.
The finding that several outcome measures were sig-
nificantly worse at teaching hospitals was somewhat sur-
prising. Kazmers et al6 reported that outcome after AAA
repair was improved in Veterans Affairs Medical Centers
with academic affiliations. Similarly, Roddy et al36 recently
reported that the outcome after carotid endarterectomy
was significantly better at high-volume academic medical
centers. It is conceivable that the patient populations at
the teaching and nonteaching hospitals were not compa-
rable and that the overall patient acuity and the complex-
ity of the procedures were greater at the teaching
institutions. Unfortunately, the indication for the proce-
dure was not available in the dataset, nor was any severity
of illness or comorbidity scores. Although we did attempt
to correct individual comorbidities and their sum in the
multivariate models, the hospital characteristics were not
included in the multivariate analysis of mortality because
they did not achieve or approach statistical significance in
the univariate model. The observations that the bad out-
come rate was lower and that mortality trended towards
significantly lower rate at large hospitals was not surpris-
ing. Although we did not attempt to look at outcome by
hospital volume, hospital size is likely a reasonable surro-
gate, and multiple series have reported that operative mor-
tality rate varies inversely with the hospital volume for
repair of intact AAAs.6,7,10,11
Several additional features of the study merit further
comment. The annual number of nonruptured AAA repairs
reported is consistent with a 20% United States sample and
within the range reported by Lawrence et al (32,389) and
the Center of Disease Control (30,000, ICD-9 code
38.44).37 The accuracy of the discharge abstract is contin-
gent on the abstracters and coders. A recent survey of
Medicare claims reported a 25% error rate for the primary
diagnostic and procedure codes, although the coding of
patients with a diagnostic code for AAA was quite accu-
rate.38 The number of comorbidities and complication rates
is likely underestimated by the abstracting process, although
the errors in the system are likely random and not isolated
to a specific demographic group or hospital type. In con-
trast, the in-hospital mortality data are likely accurate
because they are finite, discrete end points. The total num-
ber of endovascular repairs inadvertently included in the
dataset was probably small because endovascular repairs
were relatively uncommon and investigational during 1994-
1996. Furthermore, they were likely coded with the proce-
dure code 39.52 (other repair of aneurysm), which was
excluded from the analyses. Finally, our dataset is subject to
the potential criticism that it excluded the complex
aneurysms repairs, and therefore, the reported mortality
rate is artificially low. This was not found to be the case
either in the report by Katz et al10 or during our own pre-
liminary analyses; the mortality rate determined from the
combination of the primary diagnostic and procedure codes
in our database was comparable to that when any one of the
15 procedure codes was used (441.4/38.44-4.2% vs
441.4/others-4.6%, data not shown).
In conclusion, the current outcome after open repair of
intact AAAs in the United States appears quite good. The
outcome after endovascular repair of intact AAAs must
compare favorably to the current results for open repair to
be considered an alternative or better treatment option for
most patients. Older, sicker patients may benefit from non-
operative treatment or the potentially lower risk endovas-
cular approach, but this remains to be documented.
We thank Rick Flug, RN, MA, and Lori M. Carlton,
RN, for their assistance.
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DISCUSSION
Dr Peter F. Lawrence (Irvine, Calif). Dr Hobson, members,
and guests. 
Dr Huber and colleagues, in this very well-written and well-
analyzed paper, have concluded that the average surgeon in the
United States, when performing an abdominal aortic aneurysm
repair on the average patient, has a 4% mortality, 30% morbidity,
and hospital charges of approximately $28,000. And that patients
who are older, have renal insufficiency, and are women do poorer.
These results are what most of us would expect.
What is intuitively illogical about the data is that patients with
hypertension did better than those without it and that patients
with ischemic heart disease had statistically significant lower mor-
tality and better overall outcomes. According to these data,
you’re safer having ischemic heart disease than not when you’re
scheduled for your elective abdominal aortic aneurysm repair.
In my opinion the devil is in the statistical details; that is, how
the data are analyzed. The authors chose to include only the pro-
cedure code for aortic aneurysm repair when it was listed as the
primary procedure, which will identify the simplest, most
straightforward aneurysms. In a study that we published last year
in the Journal of Vascular Surgery on the epidemiology of abdom-
inal aortic aneurysms, we used many more procedure codes for
abdominal aortic aneurysm and found that the overall mortality
was 8.4%, or twice Dr Huber’s data, because we believe all
infrarenal aneurysm repairs were included, not just the straight-
forward ones.
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The dataset that we used, the National Hospital Discharge
Summary, is different than this database and is considered, even by
the HIS group that provided the data for Dr Huber’s report, as
the gold standard for epidemiologic studies. Consequently, we can
assume that the average mortality in the United States for
infrarenal abdominal aortic aneurysm repair is somewhere between
4.2% and 8.4%, depending on whether complex repairs are
included or not. Until these two large datasets used by Dr Huber
and our group are merged, it will be difficult to be more precise.
Even with these cautions, this is an excellent study and con-
tributes greatly to our understanding of the epidemiology of
intact aortic aneurysms that are surgically repaired.
I have three questions. 
1. Why did you use the Nationwide Inpatient Sample, which
samples only 19 of 50 states, rather than the National
Hospital Discharge Summary, which samples all 50 states and
is considered by most to be the gold standard for large epi-
demiologic studies?
2. How did you handle a patient who had an elective abdomi-
nal aortic aneurysm repair preceding or following a coronary
artery bypass or carotid endarterectomy when the aneurysm
repair was not listed as the primary surgical procedure?
Often, the primary procedure code is the one that generates
the best reimbursement for the hospital, not the most impor-
tant procedure.
3. Lastly, could you give us a more detailed explanation for the
protective effects of hypertension and ischemic heart disease
when patients undergo elective aneurysm repair?
I enjoyed this paper greatly and compliment you on both the
presentation and the manuscript.
Dr Thomas S. Huber. I would like to respond to Dr
Lawrence’s itemized criticisms in order.
Regarding the selection of our dataset, the NIS is advertised
to be a 20% stratified national sample. The hospitals are stratified
based on the region of country, teaching affiliation, and size.
Although it encompasses only 19 separate states, it is a stratified
sample of the country as a whole. The NIS and the National
Hospital Discharge Survey that Dr Lawrence referred to have
been reported to be very comparable in other analyses.
We only identified patients by their primary procedure codes,
so patients who had a carotid endarterectomy or a coronary
artery bypass prior to their aneurysm would not have been
included. I do take objection to Dr Lawrence’s statement that we
analyzed the simpler or less complex aneurysms. That wasn’t our
intention. Our intention was to identify patients who underwent
aneurysm repair, period. We used the primary diagnostic code for
aneurysm ICD-9 code, 38.44, which captured roughly 80% of all
aortic reconstructions that could potentially have been due to
aneurysms. If we had used any procedure code and any diagnos-
tic code, we would have captured about 22,000 repairs. We ana-
lyzed 16,500, or roughly 70% of that larger number. When we
looked at the mortality rate using any procedure code and any
diagnostic code, the rate was 4.6% in comparison to the 4.2% that
we reported. It is noteworthy that these numbers include com-
plex aneurysm repair such as suprarenals, juxtarenals, and those
reconstructions performed concomitant with other procedures.
I didn’t touch on the potential protective effect of hyperten-
sion and ischemic heart disease diagnostic codes. These were asso-
ciated with a lower mortality and a lower bad outcome rate both
by univariate and multivariate analyses. This has been reported in
other population studies, including one from the state of
Michigan. It has been attributed to a treatment effect and perhaps
an overcoding effect by DRGs. The most plausible explanation is
that patients with these codes were identified and treated earlier.
It’s nonsensical to think that patients with ischemic heart disease
actually do better with aneurysm repairs.
Dr Jack L. Cronenwett (Lebanon, NH). Tom, I enjoyed your
paper, and I rise to support it and to ask you a question. In the
Dartmouth Atlas of Vascular Health Care, we’ve looked at the
Medicare population undergoing elective aneurysm repair based
on Part B claims data using CPT codes, which included all
infrarenal repairs. We found overall mortality rates in the United
States virtually identical to what you reported across these differ-
ent age groups. So in contrast to Dr Lawrence, I think you do
have an accurate dataset.
The question that I have is that I was somewhat surprised and
somewhat reassured that you did not see a difference in elective
operative mortality as a function of hospital size, at least as you
stratified this in your paper. In the Dartmouth Atlas, we have
shown a very direct correlation between elective operative mor-
tality and individual surgeon volume, ranging from 4% for high-
volume surgeons to 8% for low-volume surgeons. I would assume
there would be some correlation between surgeon volume and
hospital size, and I wonder if you have an explanation for this in
your series or whether you’ve looked at volume outcome in a
more precise manner?
Dr Huber. We cited the Dartmouth Atlas in our repairs, and
were reassured that the mortality rate was almost the same. It is
noteworthy that our data reflect all patients rather than only the
Medicare population or those patients over 65 years of age.
In regard to hospital volume and surgeon volume, we did not
specifically look at that outcome measure. Hospital size was used
in the database stratification but is a poor substitute for hospital
volume. However, we saw a trend toward lower mortality for
large hospital size.
Dr John H. N. Wolfe (London, UK). These are excellent
data, and the overall results are excellent. But the devil is in the
detail. Whereas overall mortality of 4% is excellent, statistically, in
patients with a much smaller aneurysm who are relatively fit, I
suspect most of us would think that this was unacceptable (cer-
tainly health economists might, because of the natural history of
the disease).
At the other end of the scale, you have shown that renal fail-
ure is the strongest association for poor outcome. And when we
looked at our figures, we were horrified to find that in an elderly
patient with a creatinine of above 180 mmol/L, there was a four-
fold increase in mortality rates. It would be interesting to look at
subsets of your data to see if one can make similar comparisons.
We need to look at the groups that are truly going to benefit from
this surgery rather than looking at the average overall group.
Dr Huber. We have performed a multivariate analysis to look
at the individual predictors of mortality and bad outcome. Both
age and renal insufficiency were associated with a dramatic
increase in bad outcome and mortality, but we haven’t looked at
the combination of the two variables together.
Dr John W. Hallett, Jr (Rochester, Minn). These data are
encouraging, and they match almost identically the mortality that
we’ve seen in the Rochester Epidemiology Project of 4.8% in-hos-
pital mortality.
John Porter challenged us this morning not to look just at
30-day results but to look at later outcome. And it seems that we
need to look at total grafting morbidity and mortality, which
includes 30 days and then what happens subsequently.
In the Rochester Epidemiology Project, we observed that the
risk for a significant late graft complication was only 7% at 10 years,
and only 1% of patients died of a complication after the first 30
days. Your patients were done between 1994 and 1996. Do you
have the data on the reoperation rates for graft complications and
any subsequent graft-related deaths? And if you don’t, I think that
late outcomes should be the next step in this important project.
Dr Huber. Unfortunately, we don’t have any longer term data.
The administrative databases that we used contain only a finite
amount of data. It doesn’t include specific patient identifiers, so
we can’t look at these longer term or longitudinal outcomes.
